PD-L1+ T細胞:腫瘍⬆️耐性 https://t.co/hZUTyFH8y0 発症時に補体が腫瘍⬇️活性→腫瘍⬆️活性に 1)PD-L1結合はCD4+ T 細胞におけるSTAT3依存 「back-signalling」誘導、活性化を妨げた https://t.co/JZQ9tZbZUl https://t.co/VDuzF5vTOC
3,269 followers
5,774 followers
RT @FrontiersIn: Article published in @FrontPharmacol reviews the current landscape of the PD-1/PD-L1 mechanistic role in #tumor immune eva…
94,390 followers
Article published in @FrontPharmacol reviews the current landscape of the PD-1/PD-L1 mechanistic role in #tumor immune evasion and therapeutic outcome for #cancertreatment. Free download: https://t.co/cInVHuFWnW https://t.co/ioVQoWMhIp
5,774 followers
Looking back at 2017: check out this review on PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy as part of our #weeklyreads https://t.co/Jt73LUnbfE #CancerImmunotherapy #Frontiers #OpenAccess